Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Applied logistic regression

Choice Reviews Online · 1990 · 35.7K citations

Public Health, Biostatistics, Clinical Epidemiology +15

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 641 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Harry J. Long, Brian N. Bundy, Edward C. Grendys et al. · Journal of Clinical Oncology · 2005 · 557 citations

Medicine, Gynecology, Oncology +13

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

G Omura, J A Blessing, Luis Vaccarello et al. · Journal of Clinical Oncology · 1997 · 275 citations

Medicine, Oncology, Pharmacology +11

Racial Disparities Among Patients With Lung Cancer Who Were Recommended Operative Therapy

Farhood Farjah · Archives of Surgery · 2009 · 138 citations · Full text

Medicine, Oncology, Surgery +16